ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Celldex Therapeutics (CLDX) Technical (Analysis) Reports Celldex Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Celldex Therapeutics (CLDX)

Technical Analysis Report for NASDAQ stock CLDX Celldex Therapeutics. Dated: 11 Sep 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology In Vitro In Vivo Diagnostic Substances in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock CLDX Celldex Therapeutics then click here. or read Experts views on Celldex Therapeutics or Forecast & share price targets of Celldex Therapeutics

Celldex Therapeutics Opened at 38.39 and Closed at: 36.90, which is -3.25% of previous session's close. It moved within a range of 36.84 and 38.59
The session was a Bearish session with an average volume of 1033500, which is 8.18% of previous session's volumes.

  • The stock has fallen, and its short term trend is also negative and in a downtrend.
  • There is some negative change in the mid term trend, but its too soon to jump onto conclusions.
  • Even though the stock has fallen, but its long term trend is positive and in an uptrend.

A Dead cross was found 1 days back on mid term averages

Support for tomorrow is 36 and resistance for tomorrow is 37.75
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 36.3, 35.69 resistance for tomorrow's hourly charts is 38.05, 39.19

10 Day SMA for Celldex Therapeutics (CLDX) is 38.94 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Celldex Therapeutics (CLDX) is 40 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Celldex Therapeutics (CLDX) is 39.07 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 35.71 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Celldex Therapeutics is 31.88 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Celldex Therapeutics is at 40 and 200 DMA is at 31.88, while 50 DMA and 100 DMA are at 39.07 and 35.71 respectively

Celldex Therapeutics (CLDX) moving average of 20 SMA is at 40 and 20 EMA is at 39.41

Celldex Therapeutics (CLDX) moving average of 50 SMA is at 39.07 and 50 EMA is at 38.54

Celldex Therapeutics (CLDX) moving average of 100 SMA is at 35.71 and 100 EMA is at 36.31

Celldex Therapeutics (CLDX) moving average of 200 SMA is at 31.88 and 200 EMA is at 32.82

Celldex Therapeutics has performed better than Xeris Pharmaceuticals in short term. Holding Celldex Therapeutics could be a better choice for now!

Savara Inc has performed better than Celldex Therapeutics in short term. You could have earned much better returns by investing in Savara Inc, about 10.55% more returns!

Celldex Therapeutics has performed better than Synergetics Usa in short term. Holding Celldex Therapeutics could be a better choice for now!

Riot Blockchain has performed better than Celldex Therapeutics in short term. You could have earned much better returns by investing in Riot Blockchain, about 24.92% more returns!

Redhill Biopharma has performed better than Celldex Therapeutics in short term. You could have earned much better returns by investing in Redhill Biopharma, about 18.71% more returns!

Prothena Corporation has performed better than Celldex Therapeutics in short term. You could have earned much better returns by investing in Prothena Corporation, about 12.83% more returns!

Opko Health has performed better than Celldex Therapeutics in short term. You could have earned much better returns by investing in Opko Health, about 25.81% more returns!

Novocure has performed better than Celldex Therapeutics in short term. You could have earned much better returns by investing in Novocure, about 3.54% more returns!

Novavax Inc has performed better than Celldex Therapeutics in short term. You could have earned much better returns by investing in Novavax Inc, about 29.06% more returns!

Celldex Therapeutics has performed better than Kodiak Sciences in short term. Holding Celldex Therapeutics could be a better choice for now!

Celldex Therapeutics has performed better than Jaguar Health in short term. Holding Celldex Therapeutics could be a better choice for now!

Insmed Inc has performed better than Celldex Therapeutics in short term. You could have earned much better returns by investing in Insmed Inc, about 16.62% more returns!

Audentes Therapeutics has performed better than Celldex Therapeutics in short term. You could have earned much better returns by investing in Audentes Therapeutics, about 12.04% more returns!

Cellectis S has performed better than Celldex Therapeutics in short term. You could have earned much better returns by investing in Cellectis S, about 13.68% more returns!

Celldex Therapeutics has performed better than Corvus Pharmaceuticals in short term. Holding Celldex Therapeutics could be a better choice for now!

Celldex Therapeutics Technical analysis of indicators

Price action analysis of Celldex Therapeutics (CLDX) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Celldex Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a SELL signal for Celldex Therapeutics in short term and the sell signal is strong.

Celldex Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Celldex Therapeutics in short term and SELL signal is strong!

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Celldex Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 38.69 and Celldex Therapeutics CLDX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Celldex Therapeutics CLDX stock. Volume based technical analysis of Celldex Therapeutics CLDX stock is negative.

Celldex Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock CLDX Celldex Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And CLDX Experts View which covers a lot of information including buying and selling signals

CLDX future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Celldex Therapeutics or View Candle Stick Charts here

Chart Celldex Therapeutics (CLDX)  Technical (Analysis) Reports Celldex Therapeutics [

Videos related to: Celldex Therapeutics (CLDX) Technical (Analysis) Reports Celldex Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Celldex Therapeutics (CLDX)  Technical (Analysis) Reports Celldex Therapeutics [

 

Back to top